All In Biotech

Drug Trial Radar · NCT01271985

Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians Using a Single PolyPill

Fixed-dose Combination Therapy (PolyPill) in Primary and Secondary Prevention of Cardiovascular Disease in Middle-aged and Elderly Iranians

Last checked: Nov 19, 2026Latest source record: Jan 22, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 8,410 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

8,410

Actual

Start

Feb 2011

Primary completion

Jan 2019

Study completion Jan 2019

Sponsor

Lead sponsor
Tehran University of Medical SciencesAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Golestan University of Medical sciences; University of Birmingham
First posted
Jan 7, 2011

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
Who can join
All sexes, from 50 years, up to 79 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effects of PolyPill tablet (a fixed dose combination of two anti-hypertensive medications, atorvastatin and aspirin) on primary and secondary prevention of cardiovascular disease in Iranian adults older than 50.

Conditions

  • Cardiovascular Diseases

Interventions

  • PolyPillDrug

    A combination tablet containing Aspirin 81 mg, enalapril 5 mg (or valsartan 40 mg), atorvastatin 20 mg and hydrochlorothiazide 12.5 mg taken once daily

  • Minimal careOther

    Health education pamphlet on reducing cardiovascular risk factors, direct education on reducing cardiovascular risk factors provided by the study physician and the Community Health Worker, biannual follow-up and BP measurement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to first major cardiovascular eventTime frame: 5 years

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Golestan Cohort Study Center

    Gonbad, Golestan Province, Iran

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.